Papers
1
Total Citations
19
H-Index
1
About
Zhongqiu Wang is a clinical researcher whose work centers on the application of stereotactic body radiation therapy (SBRT) for metastatic disease, with a particular focus on the CyberKnife robotic system. His most cited study, "Stereotactic body radiation therapy induces fast tumor control and symptom relief in patients with iliac lymph node metastasis" (2016, 19 citations), provides critical evidence that SBRT can achieve rapid local control and effective symptom palliation for iliac lymph node metastases with minimal toxicity. This work demonstrates Wang's contribution to expanding the role of non-invasive, high-precision radiotherapy in managing oligometastatic disease, offering patients a treatment alternative that balances efficacy with quality of life. By systematically evaluating outcomes in this specific anatomical site, Wang has helped refine clinical protocols for CyberKnife SBRT, informing oncologists about its potential to deliver durable tumor control while sparing surrounding healthy tissue. His research underscores the growing importance of robotic radiosurgery in modern oncology, particularly for patients with limited metastatic burden seeking fast symptom relief and improved local outcomes.
Research Focus
Key Achievements
Top Papers
- 1